AMANDA ODE: Open Payments
NPI 1154820231 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,595 in 173 payments from 29 companies in 2025. Trend: 2023 $1,612 · 2024 $4,008 · 2025 $4,595
Food & beverage: $4,595
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 30 | $679 |
| Insulet Corporation | 18 | $532 |
| Corcept Therapeutics | 14 | $466 |
| Sequel Med Tech, LLC | 13 | $412 |
| Abbott Laboratories | 8 | $286 |
| Lilly USA, LLC | 12 | $258 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $215 |
| Mannkind Corporation | 10 | $213 |
| Tandem Diabetes Care, Inc. | 5 | $206 |
| Novo Nordisk Inc | 12 | $153 |
Products named: TEPEZZA, Omnipod, Korlym, TWIIST, JARDIANCE, FREESTYLE LIBRE 3, AFREZZA, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across NY — which companies pay providers there.
